Surface Oncology
SURF
#9617
Rank
โ‚ฌ55.91 M
Marketcap
0,92ย โ‚ฌ
Share price
0.00%
Change (1 day)
-4.30%
Change (1 year)

Operating Margin for Surface Oncology (SURF)

Operating Margin as of January 2026 (TTM): -182.62%

According to Surface Oncology's latest financial reports and stock price the company's current Operating Margin is -182.62%. At the end of 2021 the company had an Operating Margin of -2,826.16%.

Operating Margin history for Surface Oncology from 2017 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-2,826.16%-5889.54%
202048.82%-113.07%
2019-373.48%2324.97%
2018-15.40%-95.7%
2017-358.57%32.08%
2016-271.47%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
ORIC Pharmaceuticals
ORIC
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.